Chameleon Biosciences

Developer of gene delivery technology for pediatric disorders

placeBerkeley, California, United States calendar_todayFounded 2017 groups17 employees language chameleonbiosci.com

Innovation

2 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 120 times.

YearFilings
20191
20201
20211
20232

Investor mix

11 investors on record; lead investors include Matrix Partners China, Berkeley SkyDeck, CureDuchenne.

Investor typeCountShare
Venture capital873%
Private equity19%
Accelerator & incubator19%
Other / undisclosed19%
Coming soon